Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
World Journal of Gastroenterology
Automatic slicing system: Ex-vivo culture normal and cancerous pancreatic tissue
April 7th, 2009
Pancreatic cancer is a devastating disease with a very poor prognosis. This warrants the development of novel therapies including gene therapy. Several of these treatments were found to be effective in pre-clinical (animal) models. However, in the subsequent clinical studies in patients the results were disappointing. The discrepancy between pre-clinical models and results seen in patients underscores the need for pre-clinical models that more reliable predict the clinical efficacy. A research article to be published on March 21,2009 of the World Journal of Gastroenterology addresses this problem and presents a novel model system more comparable to the in vivo situation...
Source: Cancer Weekly (2009-04-07)
|
